Beijing Zeta Medical Technology Co. Ltd. is an active, enthusiastic, and dynamic professional provider of intelligent medical services. Using information and big data technology, we are approaching our original intention to provide high-quality digital solutions for China's health industry. We take "digital health, precise management" as our mission; "integrity, focus, and empathy" as our principles; and "artificial intelligence technology" as our trump card. We will use new technologies to drive new models and, finally, to promote mutual benefit and win-win results. Relying on our rich industry experience and our professional and efficient technical team, we have developed many like-minded partners. On the way to medical information innovation, we invite you to create together!
Beijing Zeta Medical Technology Co. Ltd. has participated in the China Standard Diagnosis and Treatment Center for Atopic Dermatitis Project as the medical information technology provider. The project aims to benefit 10,000 patients with atopic dermatitis, and strictly manage 5,000 patients with moderate to severe atopic dermatitis.
Patients with moderate to severe atopic dermatitis need to be followed up for a long time to understand the changes in their condition because of repeated medical treatment. At the same time, as the symptoms of dermatitis seriously affect physical and mental health, long-term guidance is needed. In this context, the project uses our MP2 Research Platform to enroll patients, conduct long-term follow-up and information collection for patients, and provide targeted patient education materials to guide patients' self-management.
Beijing Zeta Medical Technology Co. Ltd. has participated in the biological therapy project for atopic dermatitis at Hainan Boao Super Hospital as the medical information technology provider. The establishment of Boao Super Hospital in Hainan is intended to be an expert discussion platform for new medical technologies, new drugs, and new devices at home and abroad. Some new technologies and therapies listed abroad can be studied and used in pilot projects. The real-world data collected in the projects and the real-world evidence generated can provide evidence for the safety and effectiveness of the treatment.
The Hainan Boao Super Hospital Atopic Dermatitis Biotherapy Project includes a real-world study on the safety and effectiveness of the new treatment. The study uses our MP2 Research Platform to collect real-world data from patients and our real-world data analysis platform to analyze the data.
Beijing Zeta Medical Technology Co. Ltd.
contact@zetahealthcare.com
010-53320410
Room 269, Building 1-C, Yard 2, Yongcheng North Road
Haidian District, Beijing
